p53

3D rendering of immune responses during cancer therapy.

Single-Cell Proteomics for Immune Profiling in Cancer

Today's Clinical Lab

Proteomics assays provide insight into cancer disease and treatment response, allowing for potent and durable therapies

Bispecific antibodies, comprising one component that specifically recognizes cancer cells and another component that recognizes immune cells, brings the cancer cells and immune cells together to destroy cancer cells.

Researches Develop Mutant Gene-Targeted Immunotherapy

Johns Hopkins Medicine

The novel immunotherapy approach uses bispecific antibodies against mutant proteins to target cancer cells

p53 Gene Discovery Sheds Light on How to Make Cancer Therapies More Effective

Virginia Commonwealth University

Study used mass spectrometry to identify proteins that interact with processes that regulate p53